Oaktop Capital Management II’s PetMed Express PETS Stock Holding History

Oaktop Capital Management II’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-435,844	Closed	-$1.09M	–	14
2025 Q3	$1.09M	Hold	435,844	–	–	0.1%	14
2025 Q2	$1.45M	Hold	435,844	–	–	0.16%	14
2025 Q1	$1.83M	Hold	435,844	–	–	0.24%	14
2024 Q4	$2.1M	Hold	435,844	–	–	0.26%	14
2024 Q3	$1.6M	Hold	435,844	–	–	0.18%	14
2024 Q2	$1.77M	Hold	435,844	–	–	0.18%	14
2024 Q1	$2.09M	Hold	435,844	–	–	0.24%	14
2023 Q4	$3.29M	Hold	435,844	–	–	0.44%	13
2023 Q3	$4.47M	Hold	435,844	–	–	0.75%	13
2023 Q2	$6.01M	Hold	435,844	–	–	0.91%	13
2023 Q1	$7.08M	Hold	435,844	–	–	1.19%	12
2022 Q4	$7.71M	Hold	435,844	–	–	1.38%	12
2022 Q3	$8.51M	Sell	435,844 -10,000	-2%	-$212K	1.71%	12
2022 Q2	$8.87M	Hold	445,844	–	–	1.61%	12
2022 Q1	$11.5M	Hold	445,844	–	–	1.64%	12
2021 Q4	$11.3M	Buy	445,844 +112,169	+34%	+$3.1M	1.36%	12
2021 Q3	$8.97M	Hold	333,675	–	–	1.24%	12
2021 Q2	$10.6M	Hold	333,675	–	–	1.52%	12
2021 Q1	$11.7M	Sell	333,675 -40,000	-11%	-$1.39M	1.81%	12
2020 Q4	$12M	Hold	373,675	–	–	2.11%	11
2020 Q3	$11.8M	Hold	373,675	–	–	2.61%	10
2020 Q2	$13.3M	Hold	373,675	–	–	3.13%	10
2020 Q1	$10.8M	Hold	373,675	–	–	3.29%	10
2019 Q4	$8.79M	Hold	373,675	–	–	2.31%	10
2019 Q3	$6.73M	Hold	373,675	–	–	1.39%	11
2019 Q2	$5.86M	Hold	373,675	–	–	1.26%	13
2019 Q1	$8.51M	Hold	373,675	–	–	1.78%	10
2018 Q4	$8.69M	Hold	373,675	–	–	2.42%	10
2018 Q3	$12.3M	Hold	373,675	–	–	2.75%	10
2018 Q2	$16.5M	Hold	373,675	–	–	3.61%	8
2018 Q1	$15.6M	Hold	373,675	–	–	3.27%	8
2017 Q4	$17M	Hold	373,675	–	–	3.42%	7
2017 Q3	$12.4M	Hold	373,675	–	–	2.07%	9
2017 Q2	$15.2M	Hold	373,675	–	–	2.78%	8
2017 Q1	$7.53M	Hold	373,675	–	–	1.49%	11
2016 Q4	$8.62M	Hold	373,675	–	–	1.88%	9
2016 Q3	$7.58M	Hold	373,675	–	–	1.77%	10
2016 Q2	$7.01M	Hold	373,675	–	–	1.7%	11
2016 Q1	$6.69M	Hold	373,675	–	–	1.62%	12
2015 Q4	$6.41M	Hold	373,675	–	–	1.43%	11
2015 Q3	$6.02M	Hold	373,675	–	–	1.35%	15
2015 Q2	$6.45M	Hold	373,675	–	–	1.37%	13
2015 Q1	$6.17M	Hold	373,675	–	–	1.36%	13
2014 Q4	$5.37M	Hold	373,675	–	–	1.19%	14
2014 Q3	$5.08M	Hold	373,675	–	–	1.26%	13
2014 Q2	$5.04M	Hold	373,675	–	–	1.16%	14
2014 Q1	$5.01M	Buy	373,675 +121,174	+48%	+$1.68M	1.28%	14
2013 Q4	$4.2M	Buy	252,501 +170,832	+209%	+$2.67M	0.99%	14
2013 Q3	$1.33M	Buy	81,669 +19,769	+32%	+$308K	0.33%	16
2013 Q2	$780K	Buy	+61,900	New	+$807K	0.23%	18

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPH

Steel Partners Holdings New York $96.4M AUM

Oaktop Capital Management II's PETS Position: Q4 2025 in Review

Oaktop Capital Management II sold out of PetMed Express (PETS) in Q4 2025, closing a stake of 435,844 shares — an estimated $1.09M sold.

Oaktop Capital Management II first reported a position in PETS in Q2 2013 and held it in 50 quarters. The position peaked at $17M in Q4 2017. 51 funds tracked by Wall St. Rank hold PETS as of Q4 2025.

Oaktop Capital Management II reported no remaining PetMed Express position as of Q4 2025 after selling out during the quarter.
Oaktop Capital Management II sold 435,844 PetMed Express shares in Q4 2025, an estimated $1.09M.
Oaktop Capital Management II first reported a position in PetMed Express in Q2 2013 and held it in 50 quarters.
Oaktop Capital Management II's PetMed Express position peaked at $17M in Q4 2017.
51 funds tracked by Wall St. Rank held PetMed Express as of Q4 2025.

Based on Oaktop Capital Management II's 13F filing for Q4 2025, filed 17 Feb 2026.